يعرض 1 - 10 نتائج من 24 نتيجة بحث عن '"Bone Density Conservation Agent"', وقت الاستعلام: 0.80s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Early Denosumab for the prevention of osteoporotic fractures in breast cancer women undergoing aromatase inhibitors: A case-control retrospective study

    المؤلفون: Scaturro D., De Sire A., Terrana P., Curci C., Vitagliani F., Falco V., Cuntrera D., Iolascon G., Mauro G. L.

    المساهمون: Scaturro, D., De Sire, A., Terrana, P., Curci, C., Vitagliani, F., Falco, V., Cuntrera, D., Iolascon, G., Mauro, G. L.

    مصطلحات موضوعية: bone health, breast cancer, denosumab, Osteoporosi, risk of fracture, Aged, Aromatase Inhibitor, Bone Density, Case-Control Studie, Female, Human, Middle Aged, Retrospective Studie, Bone Density Conservation Agent, Breast Neoplasm, Osteoporosis, Postmenopausal, Osteoporotic Fractures

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34092604; info:eu-repo/semantics/altIdentifier/wos/WOS:000750031000025; volume:35; issue:1; firstpage:207; lastpage:212; numberofpages:6; journal:JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION; https://hdl.handle.net/11591/489681Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123285832

    الإتاحة: https://doi.org/10.3233/BMR-210012Test
    https://hdl.handle.net/11591/489681Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors

    المؤلفون: Mazziotti, Gherardo, Pedersini, Rebecca, Vena, Walter, Cosentini, Deborah, Carrone, Flaminia, Pigni, Stella, Simoncini, Edda L, Torrisi, Rosalba, Zambelli, Alberto, Farina, Davide, Balzarini, Luca, Lania, Andrea G, Berruti, Alfredo

    المساهمون: Mazziotti, Gherardo, Pedersini, Rebecca, Vena, Walter, Cosentini, Deborah, Carrone, Flaminia, Pigni, Stella, Simoncini, Edda L, Torrisi, Rosalba, Zambelli, Alberto, Farina, Davide, Balzarini, Luca, Lania, Andrea G, Berruti, Alfredo

    مصطلحات موضوعية: Aromatase inhibitor, Bisphosphonate, Bone mineral density, Denosumab, Osteoporosi, Vertebral fracture, Bone Density, Child, Preschool, Diphosphonate, Female, Human, Prospective Studie, Zoledronic Acid, Bone Density Conservation Agent, Breast Neoplasm, Fractures, Bone, Spinal Fractures

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35902384; info:eu-repo/semantics/altIdentifier/wos/WOS:000832486100001; volume:111; issue:5; firstpage:466; lastpage:474; numberofpages:9; journal:CALCIFIED TISSUE INTERNATIONAL; http://hdl.handle.net/11379/564185Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85136866350

    الإتاحة: https://doi.org/10.1007/s00223-022-01011-wTest
    http://hdl.handle.net/11379/564185Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

    المؤلفون: Coleman, R, Powles, T, Paterson, A, Gnant, M, Anderson, S, Diel, I, Gralow, J, von Minckwitz, G, Moebus, V, Bergh, J, Pritchard, K. I, Bliss, J, Cameron, D, Evans, V, Pan, H, Peto, R, Bradley, R, Gray, R, DE LAURENTIIS, MICHELINO

    المساهمون: Coleman, R, Powles, T, Paterson, A, Gnant, M, Anderson, S, Diel, I, Gralow, J, von Minckwitz, G, Moebus, V, Bergh, J, Pritchard, K. I, Bliss, J, Cameron, D, Evans, V, Pan, H, Peto, R, Bradley, R, Gray, R, DE LAURENTIIS, Michelino

    مصطلحات موضوعية: Bone Density Conservation Agent, Breast Neoplasm, Chemotherapy, Adjuvant, Diphosphonate, Drug Administration Schedule, Female, Humans

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000362316200028; volume:386; issue:10001; firstpage:1353-61; journal:THE LANCET; http://hdl.handle.net/11588/667909Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84944177030

    الإتاحة: https://doi.org/10.1016/S0140-6736Test(15)60908-4
    http://hdl.handle.net/11588/667909Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials

    المؤلفون: Antonio Russo, Francesca Toia, Sergio Rizzo, Giuseppe Badalamenti, Viviana Bazan, Francesco Pantano, Giuseppe Tonini, Daniele Santini, L. Castellana, Antonio Galvano, Lorena Incorvaia, Bruno Vincenzi, Fiorella Guadagni, Giovanna Giuliana

    المساهمون: Santini D., Galvano A., Pantano F., Incorvaia L., Rizzo S., Vincenzi B., Castellana L., Giuliana G., Guadagni F., Toia F., Tonini G., Russo A., Badalamenti G., Bazan V.

    مصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_specialty, Meta-Analysi, Bone Density Conservation Agent, medicine.medical_treatment, Bone Neoplasms, Breast Neoplasms, Bone Neoplasm, Zoledronic Acid, law.invention, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Humans, Hypocalcaemia, Breast, Adverse effect, Bone Density Conservation Agents, Solid tumor, business.industry, Mortality rate, Prostate, Prostatic Neoplasms, AE, Hematology, Bisphosphonate, SMR, medicine.disease, Bone metastase, 030104 developmental biology, Zoledronic acid, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Meta-analysis, Prostatic Neoplasm, Female, business, Breast Neoplasm, medicine.drug, Human

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe4b1ee9f8a60e3367e930d0e3670ffTest
    http://hdl.handle.net/10447/407081Test


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials

    المؤلفون: Santini D., Galvano A., Pantano F., Incorvaia L., Rizzo S., Vincenzi B., Castellana L., Giuliana G., Guadagni F., Toia F., Tonini G., Russo A., Badalamenti G., Bazan V.

    المساهمون: Santini D., Galvano A., Pantano F., Incorvaia L., Rizzo S., Vincenzi B., Castellana L., Giuliana G., Guadagni F., Toia F., Tonini G., Russo A., Badalamenti G., Bazan V.

    مصطلحات موضوعية: AE, Bone metastase, Breast, Meta-Analysi, Prostate, SMR, Solid tumor, Zoledronic acid, Bone Density Conservation Agent, Bone Neoplasm, Breast Neoplasm, Female, Human, Male, Prostatic Neoplasm, Treatment Outcome

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31377434; info:eu-repo/semantics/altIdentifier/wos/WOS:000488330500009; volume:142; firstpage:68; lastpage:75; numberofpages:8; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/10447/407081Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85069976238

    الإتاحة: https://doi.org/10.1016/j.critrevonc.2019.07.013Test
    http://hdl.handle.net/10447/407081Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Osteoporosis management in patients with breast cancer: EMAS position statement

    المؤلفون: Trémollieres, Florence A., Ceausu, Iuliana, Depypere, Herman, Lambrinoudaki, Irene, Mueck, Alfred, Pérez-López, Faustino R., van der Schouw, Yvonne T., Senturk, Levent M., Simoncini, Tommaso, Stevenson, John C., Stute, Petra, Rees, Margaret

    المساهمون: Trémollieres, Florence A., Ceausu, Iuliana, Depypere, Herman, Lambrinoudaki, Irene, Mueck, Alfred, Pérez-López, Faustino R., van der Schouw, Yvonne T., Senturk, Levent M., Simoncini, Tommaso, Stevenson, John C., Stute, Petra, Rees, Margaret

    مصطلحات موضوعية: Adjuvant therapy, Aromatase inhibitor, Bisphosphonate, Breast cancer, Denosumab, Fracture, Osteoporosi, Screening, Bone Density, Bone Density Conservation Agent, Breast Neoplasm, Diphosphonate, Female, Fractures, Bone, Human, Imidazole, Neoplasm Recurrence, Local, Premenopause, Biochemistry, Genetics and Molecular Biology (all), Obstetrics and Gynecology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27802892; info:eu-repo/semantics/altIdentifier/wos/WOS:000390512900012; volume:95; firstpage:65; lastpage:71; numberofpages:7; journal:MATURITAS; http://hdl.handle.net/11568/907308Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84997108065; www.elsevier.com/locate/maturitas

    الإتاحة: https://doi.org/10.1016/j.maturitas.2016.10.007Test
    http://hdl.handle.net/11568/907308Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the 'biological window therapy'

    المؤلفون: Elena A Takano, Giulia Brugnoli, Manuela Milan, Laura B Pritzker, Daniele Santini, Sergio Venturini, Alberto Bottini, Carla Strina, Mara Bonelli, Daniele Generali, Claudia Fumarola, Chiara Foroni, Pier Giorgio Petronini, Vanessa Zanoni, Ramona Bertoni, Mariarosa Cappelletti, Giuseppina Ferrero, Mara Maldotti, Amadeo M. Parissenti, Stephen B. Fox, Daniele Andreis, Kenneth P.H. Pritzker

    المساهمون: Foroni, Chiara, Milan, Manuela, Strina, Carla, Cappelletti, Mariarosa, Fumarola, Claudia, Bonelli, Mara, Bertoni, Ramona, Ferrero, Giuseppina, Maldotti, Mara, Takano, Elena, Andreis, Daniele, Venturini, Sergio, Brugnoli, Giulia, Petronini, Pier Giorgio, Zanoni, Vanessa, Pritzker, Laura, Pritzker, Kenneth, Parissenti, Amadeo, Santini, Daniele, Fox, Stephen B., Bottini, Alberto, Generali, Daniele

    المصدر: Breast Cancer Research and Treatment. 144:113-121

    مصطلحات موضوعية: Oncology, BREAST CANCER, CIRCULATING TUMOR CELLS, KI67, WINDOW THERAPY, ZOLEDRONIC ACID, ADULT, AGED, 80 AND OVER, BONE DENSITY CONSERVATION AGENTS, BONE NEOPLASMS, BREAST NEOPLASMS, DIPHOSPHONATES, FEMALE, HUMANS, IMIDAZOLES, IMMUNOHISTOCHEMISTRY, MIDDLE AGED, NEOPLASTIC CELLS, CIRCULATING, ONCOLOGY, CANCER RESEARCH, Cancer Research, Pathology, CD34, Neoplastic Cells, Basal (phylogenetics), Breast cancer, Circulating tumor cell, Window therapy, 80 and over, Circulating, Aged, 80 and over, Bone Density Conservation Agents, Diphosphonates, BREAST CANCER, CIRCULATING TUMOR CELLS, KI67, WINDOW THERAPY, ZOLEDRONIC ACID, ADULT, AGED, AGED, 80 AND OVER, BONE DENSITY CONSERVATION AGENTS, BONE NEOPLASMS, BREAST NEOPLASMS, DIPHOSPHONATES, FEMALE, HUMANS, IMIDAZOLES, IMMUNOHISTOCHEMISTRY, MIDDLE AGED, NEOPLASTIC CELLS, CIRCULATING, ONCOLOGY, CANCER RESEARCH, Imidazoles, Bone metastasis, Middle Aged, Neoplastic Cells, Circulating, Immunohistochemistry, Diphosphonate, Settore SECS-S/01 - STATISTICA, Female, Ki67, Breast Neoplasm, Human, medicine.drug, Adult, medicine.medical_specialty, Bone Density Conservation Agent, Bone Neoplasms, Breast Neoplasms, Bone Neoplasm, Circulating tumor cells, Zoledronic acid, Aged, Humans, In vivo, Internal medicine, medicine, Imidazole, business.industry, medicine.disease, Apoptosis, business

    وصف الملف: ELETTRONICO

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc28fee3cc89969b86973cd26a726b4Test
    https://doi.org/10.1007/s10549-014-2840-yTest


    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel

    المؤلفون: Hadji, P., Coleman, Robert E., Wilson, C., Powles, T. J., Clézardin, P., Aapro, M., Costa, L., Body, J. -J., Markopoulos, C., Santini, D., Diel, I., Di Leo, A., Cameron, D., Dodwell, D., Smith, I., Gnant, M., Gray, R., Harbeck, N., Thurlimann, B., Untch, M., Cortes, J., Martin, M., Albert, U. -S., Conte, P. -F., Ejlertsen, B., Bergh, J., Kaufmann, M., Holen, I.

    المساهمون: Hadji, P., Coleman, Robert E., Wilson, C., Powles, T. J., Clézardin, P., Aapro, M., Costa, L., Body, J. -J., Markopoulos, C., Santini, D., Diel, I., Di Leo, A., Cameron, D., Dodwell, D., Smith, I., Gnant, M., Gray, R., Harbeck, N., Thurlimann, B., Untch, M., Cortes, J., Martin, M., Albert, U. -S., Conte, P. -F., Ejlertsen, B., Bergh, J., Kaufmann, M., Holen, I.

    مصطلحات موضوعية: Adjuvant, Bisphosphonate, Breast cancer, Guideline, Antineoplastic Agent, Bone Density Conservation Agent, Bone Neoplasm, Breast Neoplasm, Chemotherapy, Clodronic Acid, Consensu, Diphosphonate, Europe, Female, Human, Imidazole, Neoplasm Recurrence, Local, Osteoporosi, Surveys and Questionnaire, Hematology, Oncology

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26681681; info:eu-repo/semantics/altIdentifier/wos/WOS:000371691600005; volume:27; issue:3; firstpage:379; lastpage:390; numberofpages:12; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11577/3255676Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84959879550; http://annonc.oxfordjournals.orgTest/

    الإتاحة: https://doi.org/10.1093/annonc/mdv617Test
    http://hdl.handle.net/11577/3255676Test
    http://annonc.oxfordjournals.orgTest/

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: Proof from the 'biological window therapy'

    المؤلفون: Foroni, Chiara, Milan, Manuela, Strina, Carla, Cappelletti, Mariarosa, Fumarola, Claudia, Bonelli, Mara, Bertoni, Ramona, Ferrero, Giuseppina, Maldotti, Mara, Takano, Elena, Andreis, Daniele, Venturini, Sergio, Brugnoli, Giulia, Petronini, Pier Giorgio, Zanoni, Vanessa, Pritzker, Laura, Pritzker, Kenneth, Parissenti, Amadeo, Santini, Daniele, Fox, Stephen B., Bottini, Alberto, GENERALI, DANIELE

    المساهمون: Foroni, Chiara, Milan, Manuela, Strina, Carla, Cappelletti, Mariarosa, Fumarola, Claudia, Bonelli, Mara, Bertoni, Ramona, Ferrero, Giuseppina, Maldotti, Mara, Takano, Elena, Andreis, Daniele, Venturini, Sergio, Brugnoli, Giulia, Petronini, Pier Giorgio, Zanoni, Vanessa, Pritzker, Laura, Pritzker, Kenneth, Parissenti, Amadeo, Santini, Daniele, Fox, Stephen B., Bottini, Alberto, Generali, Daniele

    مصطلحات موضوعية: Breast cancer, Circulating tumor cell, Ki67, Window therapy, Zoledronic acid, Adult, Aged, 80 and over, Bone Density Conservation Agent, Bone Neoplasm, Breast Neoplasm, Diphosphonate, Female, Human, Imidazole, Immunohistochemistry, Middle Aged, Neoplastic Cells, Circulating, Oncology, Cancer Research

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/24469643; info:eu-repo/semantics/altIdentifier/wos/WOS:000331649300011; volume:144; issue:1; firstpage:113; lastpage:121; numberofpages:9; journal:BREAST CANCER RESEARCH AND TREATMENT; http://hdl.handle.net/11368/2857714Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84894674807; www.wkap.nl/journalhome.htm/0167-6806

    الإتاحة: https://doi.org/10.1007/s10549-014-2840-yTest
    http://hdl.handle.net/11368/2857714Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    What can we learn from the ZOOM trial?--Authors' reply

    المؤلفون: Amadori, Dino, Mercatali, Laura, Nanni, Oriana, Aglietta, Massimo, Alessi, Barbara, Gianni, Lorenzo, Farina, Gabriella, Gaion, Fernando, Santini, Daniele, Rondena, Roberta, Bogani, Paola, Ripamonti, Carla Ida, Ibrahim, Toni, BERTOLDO, Francesco

    المساهمون: Amadori, Dino, Mercatali, Laura, Nanni, Oriana, Aglietta, Massimo, Alessi, Barbara, Gianni, Lorenzo, Farina, Gabriella, Gaion, Fernando, Bertoldo, Francesco, Santini, Daniele, Rondena, Roberta, Bogani, Paola, Ripamonti, Carla Ida, Ibrahim, Toni

    مصطلحات موضوعية: Bone Density Conservation Agent, Bone Neoplasm, Breast Neoplasm, Diphosphonate, Female, Human, Imidazoles

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23993381; info:eu-repo/semantics/altIdentifier/wos/000323942500003; volume:14; issue:10; firstpage:e388; lastpage:e390; numberofpages:3; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11562/933122Test

    الإتاحة: https://doi.org/10.1016/S1470-2045Test(13)70295-X
    http://hdl.handle.net/11562/933122Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث